Plunkett Research Online: Enumeral Biomedical Holdings Inc

ENUMERAL BIOMEDICAL HOLDINGS INC (ENUMQ:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Enumeral Biomedical Holdings Inc is a biopharmaceutical company engaged in the discovery and development of novel antibody immunotherapies that help the immune system fight cancer and other diseases......



Enumeral Biomedical Holdings Inc
Ticker: ENUMQ
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 674-1865
Fax:
Address: 200 CambridgePark Drive
Suite 2000
Cambridge, MA 02140 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Kevin SarneyCEO/CFO/Chief Accounting Officer/Director/President/Treasurer/Vice President, Divisional
Wael FayadChairman of the Board/Director
See More
Enumeral Biomedical Holdings Inc is a biopharmaceutical company engaged in the discovery and development of novel antibody immunotherapies that help the immune system fight cancer and other diseases......See More See More

Auditor: Friedman LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: